143 related articles for article (PubMed ID: 33258278)
21. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
22. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
23. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
[TBL] [Abstract][Full Text] [Related]
24. Osteosarcoma: improvement in survival limited to high-grade patients only.
Jawad MU; Cheung MC; Clarke J; Koniaris LG; Scully SP
J Cancer Res Clin Oncol; 2011 Apr; 137(4):597-607. PubMed ID: 20514491
[TBL] [Abstract][Full Text] [Related]
25. Nomograms predicting overall survival and cancer-specific survival in osteosarcoma patients (STROBE).
Chen W; Lin Y
Medicine (Baltimore); 2019 Jun; 98(26):e16141. PubMed ID: 31261538
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.
Karski EE; Matthay KK; Neuhaus JM; Goldsby RE; Dubois SG
Cancer Epidemiol; 2013 Feb; 37(1):29-33. PubMed ID: 22959474
[TBL] [Abstract][Full Text] [Related]
27. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
28. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
29. Primary mobile vertebral column sarcomas: Prognostic factors vary by histologic subtypes.
Jawad MU; Farhan S; Haffner MR; Le HV; Thorpe SW; Klineberg EO; Randall RL
J Surg Oncol; 2021 Sep; 124(4):635-645. PubMed ID: 34091907
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
[TBL] [Abstract][Full Text] [Related]
31. Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008.
Duong LM; Richardson LC
J Registry Manag; 2013; 40(2):59-64. PubMed ID: 24002129
[TBL] [Abstract][Full Text] [Related]
32. Derivation and validation of a risk classification tree for patients with synovial sarcoma.
Neel DV; Ma C; Collins NB; Hornick JL; Demetri GD; Shulman DS
Cancer Med; 2023 Jan; 12(1):170-178. PubMed ID: 35670308
[TBL] [Abstract][Full Text] [Related]
33. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
34. Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study.
Yan P; Huang R; Hu P; Liu F; Zhu X; Hu P; Yin H; Zhang J; Meng T; Huang Z
J Neurooncol; 2019 Jul; 143(3):495-503. PubMed ID: 31089923
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.
Tsuchie H; Emori M; Nagasawa H; Miyakoshi N; Murahashi Y; Shimizu J; Mizushima E; Yamashita T; Shimada Y
Med Princ Pract; 2019; 28(5):425-431. PubMed ID: 30991396
[TBL] [Abstract][Full Text] [Related]
36. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.
Kelley LM; Schlegel M; Hecker-Nolting S; Kevric M; Haller B; Rössig C; Reichardt P; Kager L; Kühne T; Gosheger G; Windhager R; Specht K; Rechl H; Tunn PU; Baumhoer D; Wirth T; Werner M; von Kalle T; Nathrath M; Burdach S; Bielack S; von Lüttichau I
J Clin Oncol; 2020 Mar; 38(8):823-833. PubMed ID: 31928458
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population.
Zhu X; Huang R; Hu P; Yan P; Zhai S; Zhang J; Zhuang J; Yin H; Meng T; Yang D; Huang Z
Med Sci Monit; 2021 Feb; 27():e929154. PubMed ID: 33594036
[TBL] [Abstract][Full Text] [Related]
38. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
[TBL] [Abstract][Full Text] [Related]
39. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
[TBL] [Abstract][Full Text] [Related]
40. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
